NewsRoom Articles - Page 111 of 218

TuesdayJul 19, 2022 9:45 am

QSAM Biosciences Inc. (QSAM) Marks Milestone with Dosing of First Patient in CycloSam Clinical Trial

Treating patients with primary or secondary bone cancer remains goal, says company CEO Radiopharmaceuticals is a new class of drugs that delivers radiation therapy directly to cancer cells QSAM is working to develop CycloSam(R) as a breakthrough therapeutic for adult and pediatric bone cancer patients QSAM Biosciences (OTCQB: QSAM), a company developing a new class of drugs called radiopharmaceuticals, is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its…

MondayJul 18, 2022 9:53 am

Preclinical Study Uncovers Potential Key to Treating Deadly Brain Tumors

A new study has found an alternative approach that would make immunotherapy treatments more effective when treating brain tumors. Immunotherapy drugs are usually used to treat a range of cancers. However, glioblastoma multiforme, which is a fatal type of cancer, remains resistant to this revolutionary treatment because the immune system finds it hard to detect and target these tumors, allowing them to grow undisturbed. Researchers have been looking for ways to treat this deadly cancer whose tumors are usually hidden behind the blood-brain barrier. This location hinders drugs from crossing into the central nervous system’s fluid. For their research, the…

FridayJul 15, 2022 11:02 am

Scientists Identify Gene Behind Pediatric Bone Cancer

Scientists at the Lineberger Comprehensive Cancer Center, University of North Carolina have found that the OTUD7A gene impacts Ewing sarcoma development. Ewing sarcoma is a type of cancer that develops primarily in children and affects bones or tissues surrounding the bones. Figures show that roughly 250 young adults and children are diagnosed with this rare cancer annually in the United States. Of this number, about one-half eventually succumb to the illness, which points to the need for better treatments. The researchers, who collaborated with Atomwise Inc. on this study, published their findings in the “Advanced Science” journal. Pengda Liu, co-lead…

ThursdayJul 14, 2022 11:30 am

Study Maps How Brain Changes During Treatment for Depression

New research has mapped how an individual’s brain changes as they undergo treatment for depression. The study, which was carried out by scientists from the University of British Columbia, was focused on finding out what happened in the brain when a person underwent repetitive transcranial magnetic stimulation. This noninvasive treatment uses magnetic fields to stimulate nerve cells in an individual’s dorso-lateral prefrontal cortex. This region of the brain is involved in mood regulation. This particular treatment is usually administered when other treatment strategies, such as drugs, haven’t effectively helped a patient manage their depression. Various studies have found that antidepressants…

WednesdayJul 13, 2022 3:02 pm

Online Companies Offering Mental Health Services Come Under Spotlight

The need for therapists in the United States is currently at an all-time high, with the latest data from the CDC showing about 40% of adults in the country are struggling to find help for their substance abuse or mental health issues because of a therapist shortage. With no physical providers of the services they seek nearby, most are turning to online sources to meet their needs. Numerous digital mental health companies, such as BetterHelp, which offers access to therapy sessions, have been launched these last few years. These companies often receive backing from venture capital firms and provide a…

WednesdayJul 13, 2022 9:00 am

Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs

Silo’s partnership with UMB could yield therapeutics that limit side effects through precisely targeted delivery On February 3, 2022, Silo Pharma (OTCQB: SILO) extended its research partnership with the University of Maryland, Baltimore (“UMB”) to explore potentially lifesaving joint-homing peptides that target inflamed endothelium (a thin membrane that lines the inside of the heart and blood vessels). The ability to target inflamed tissue (while bypassing healthy organs) suggests joint-homing peptides could deliver therapeutics or fusion imaging nanoparticles to specific diseased tissues. Better imaging, lower radiation and precision, targeted dosing could enhance the therapeutic effect of current and future therapeutics and…

TuesdayJul 12, 2022 3:40 pm

Study Finds That Sex, Ethnicity May Impact Risk of Suicide After Concussion

Traumatic brain injuries are among the most difficult injuries to recover from. On top of causing issues such as speech difficulties and problems with logic, studies have found that individuals who sustain long-lasting symptoms from their injuries are more likely to develop mental health problems, including post-traumatic stress disorder (PTSD), depression and suicidal thoughts. Up to 30% of those who survive brain injuries go on to develop post-concussion syndrome, a condition that refers to long-term symptoms after a concussion. Common symptoms of post-concussive syndrome include headaches, brain fog, nausea, blurry vision and memory problems. An estimated 80% of concussion patients…

MondayJul 11, 2022 12:39 pm

New Study Finds Some Viruses Can Make You Tastier to Mosquitoes

Mosquitoes aren’t just loud and annoying, they take hundreds of thousands of lives per year by spreading diseases such as malaria, dengue fever, yellow fever and Zika. Researchers have now discovered a kind of cyclical relationship between mosquitoes and mosquito-borne viruses, including dengue fever and the Zika virus. The researchers found that once these viruses have infected humans and mice, they alter their scent and make them more attractive to mosquitoes. Attracted by your altered scent, the deadly bugs gorge on your infected blood and transport the viruses to their next victim. Once the new victim is infected, the cycle…

MondayJul 11, 2022 12:00 pm

Odyssey Health, Inc.’s (ODYY) Sports Advisory Board Enhancing Public Awareness and Understanding of Traumatic Brain Injuries

Odyssey’s Sports Advisory Board (“SAB”) was formed in 2021 to enhance public awareness of traumatic brain injuries and concussion The board’s members – Abby Wambach, Kurt Warner, and Brett Favre – have had storied careers in their respective sports and have expressed hope that scientists will examine their brains after their death to advance their understanding of head trauma Abby Wambach has committed her brain to research, hoping her efforts will bridge the gender gap in understanding sports concussions in women Sports concussions are worse for women, with female athletes being more likely to develop a sports-related concussion than their…

MondayJul 11, 2022 11:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment

Novel brain cancer drug developer CNS Pharmaceuticals, Inc. has received approval from the U.S. FDA for a Protocol Amendment that expands patient eligibility for participation in its potentially pivotal Phase 2 clinical trial for a novel drug candidate that targets the nearly 100 percent fatal cancer glioblastoma (“GBM”) CNS is developing the drug candidate Berubicin as an alternative to the standard-of-care chemotherapy agent, Lomustine, with the hope that Berubicin will prove itself at least as effective and potentially more so Berubicin has demonstrated the capacity to cross the blood-brain barrier in order to attack central nervous system tumors directly, which…